Fierce Pharma

J&J positions its PARP combo Akeega in new prostate cancer subset with 2nd FDA nod

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
Medscape

Do Lower Urinary Tract Symptoms Lead to Unnecessary Prostate Cancer Testing?

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...
Fierce Biotech

Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...
Oncology Nurse Advisor

Hormone Therapy Worsens Lipids and Elevates CV Risk in Prostate Cancer

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.
Medscape

These 4 Questions Could Unlock the Cause of Prostate Cancer

So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...
CURE

Breaking Down the Prostate Cancer Treatment Renaissance

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

Watchdog bans ads for at-home prostate cancer testing kits and supplements

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...
KMA Radio

Sundays With Mike: Yes, I have prostate cancer

5. This is NOT a death sentence. I know, any form of cancer can be lethal. I also know that prostate cancer is one of the ...